glp 1 agonists anesthesia How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Top GLP-1 Agonists Balance Weight
Description
Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point
Benefits of GLP-1s Beyond Weight Loss: Neurodegenerative and Joint Disorders Theres even interesting data emerging around neurodegenerative conditions such as Parkinsons and Alzheimers disease
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors: a narrative review of head-to-head comparisons
Winners will pair low price with fast regulatory clearance, device equivalence, and contracted access
Current and future pharmacological therapies for NAFLD/NASH
